CYP2B6 and tuberculosis: ABCB1 3435TT, CYP2B6*6/*6 and slow NAT2 acetylators genotypes were identified as pharmacogenetic biomarkers for the development of ARV and anti-TB DILI in Ethiopian TB-HIV co-infected patients.